Substituted imidazopyridazines

US9512130B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Marcus Koppitz · Berlin, DE
• Ulrich Klar · Berlin, DE
• Antje Margret Wengner · Berlin, DE
• Roland Neuhaus · Berlin, DE
• Gerhard Siemeister · Berlin, DE
• Michael Brüning

Key dates

• Filing date: Feb 25, 2014
• Grant date: Dec 6, 2016
• Expiry date: Feb 25, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2039/505
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted imidazopyridazine compounds, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.